2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Patent Ductus Arteriosus: new trials by email Literature Review of Patent Ductus Arteriosus trials Research Report on Patent Ductus Arteriosus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus pharmacologic treatment of the PDA, no pharmacologic treatment of the PDA, NSAID - Patent Ductus Arteriosus, Surgery | Phase 2 | Completed | University of California, San Francisco | 202 | 2013-12-01 | 2018-11-30 |
| Comparison of 2 Different Indomethacin Dosing Protocols to Treat Infants Delivered at <28 Weeks Gestation With a Persistent Patent Ductus Arteriosus indomethacin (two different dosing regimens) - Patent Ductus Arteriosus | Phase 2 | Completed | University of California, San Francisco | 100 | 2003-08-01 | 2008-06-04 |
Ductus Arteriosus, Patent (2) · Enterocolitis, Necrotizing (2) · Intestinal Perforation (1) · Premature Birth (1)
Cardiovascular Abnormalities (2) · Cardiovascular Diseases (2) · Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Digestive System Diseases (2) · Enterocolitis (2) · Gastroenteritis (2) · Gastrointestinal Diseases (2) · Heart Defects, Congenital (2) · Heart Diseases (2) · Intestinal Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (1) · Obstetric Labor Complications (1) · Obstetric Labor, Premature (1) · Pregnancy Complications (1)
Anti-Inflammatory Agents, Non-Steroidal (1) · Indomethacin (1)
University of California, San Francisco (2)
United States (2) · Sweden (1) · Turkey (Türkiye) (1) · United Kingdom (1)
Ronald Clyman, M.D. (1) · Ronald Clyman, MD (1)